AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 103 filers reported holding AKERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 4.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $6,462 | +74.5% | 168,900 | +149.9% | 0.01% | +80.0% |
Q4 2022 | $3,704 | -99.8% | 67,600 | +5.5% | 0.01% | +66.7% |
Q3 2022 | $2,183,000 | +89.7% | 64,100 | -47.4% | 0.00% | +200.0% |
Q2 2022 | $1,151,000 | +52.9% | 121,800 | +129.4% | 0.00% | 0.0% |
Q1 2022 | $753,000 | -80.5% | 53,100 | -64.6% | 0.00% | -75.0% |
Q4 2020 | $3,867,000 | +246.8% | 149,900 | +314.1% | 0.00% | +300.0% |
Q3 2020 | $1,115,000 | +29.8% | 36,200 | +5.0% | 0.00% | 0.0% |
Q2 2020 | $859,000 | – | 34,484 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |